Osteoarthritis affects millions worldwide, causing joint pain and mobility issues.
In the groundbreaking AutoCRAT project, researchers are pioneering a cutting-edge, automated approach to stem cell-based treatments for osteoarthritis.
This video delves into how automation enhances the manufacturing of induced pluripotent stem cells (iPSCs) and mesenchymal stem cells (MSCs)—ensuring cost-effectiveness, reduced contamination risks, and improved scalability.
By integrating advanced robotic platforms, deep learning-powered microscopy, and biochemical analysis, the AutoCRAT system streamlines stem cell production.
This innovation not only holds promise for osteoarthritis patients but also has far-reaching implications for treating various other diseases through scalable regenerative medicine solutions.
Watch the video to explore how automation is transforming the future of stem cell therapy!
